Correlation Between Pfizer and Matson Money
Can any of the company-specific risk be diversified away by investing in both Pfizer and Matson Money at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Matson Money into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and Matson Money Equity, you can compare the effects of market volatilities on Pfizer and Matson Money and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Matson Money. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Matson Money.
Diversification Opportunities for Pfizer and Matson Money
0.04 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Pfizer and Matson is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Matson Money Equity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Matson Money Equity and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Matson Money. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Matson Money Equity has no effect on the direction of Pfizer i.e., Pfizer and Matson Money go up and down completely randomly.
Pair Corralation between Pfizer and Matson Money
Considering the 90-day investment horizon Pfizer Inc is expected to generate 1.26 times more return on investment than Matson Money. However, Pfizer is 1.26 times more volatile than Matson Money Equity. It trades about -0.04 of its potential returns per unit of risk. Matson Money Equity is currently generating about -0.05 per unit of risk. If you would invest 2,599 in Pfizer Inc on December 28, 2024 and sell it today you would lose (78.00) from holding Pfizer Inc or give up 3.0% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 98.36% |
Values | Daily Returns |
Pfizer Inc vs. Matson Money Equity
Performance |
Timeline |
Pfizer Inc |
Matson Money Equity |
Pfizer and Matson Money Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and Matson Money
The main advantage of trading using opposite Pfizer and Matson Money positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Matson Money can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Matson Money will offset losses from the drop in Matson Money's long position.Pfizer vs. Emergent Biosolutions | Pfizer vs. Bausch Health Companies | Pfizer vs. Neurocrine Biosciences | Pfizer vs. Teva Pharma Industries |
Matson Money vs. Pace International Emerging | Matson Money vs. Saat Moderate Strategy | Matson Money vs. Angel Oak Multi Strategy | Matson Money vs. Prudential Emerging Markets |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |